PMPRB report reviews new drugs and their potential impact on future drug spending in Canada
Imported from official source
The latest edition of Meds Pipeline Monitor provides stakeholders with a list of new medicines in the late stages of clinical evaluation that may significantly impact clinical practice or drug spending in the coming years.
This version
- Version
- 1 of 1
- Recorded
- October 03, 2026 20:43
- Change
- Initial
- Content hash
eb984fe9d4a20b12b1f0747d35297b39- All versions
- Revision history